05/27/2022 | Press release | Distributed by Public on 05/27/2022 00:59
Please select the service you want to use:
Smartlinks | Protalix BioTherapeutics Inc. | News | Health | Biotechnology | Biotechnology | Science | Biology | Biotechnology | Research | Company News | Top Company News | Business Announcement | Products and Services | Corporate Litigation and Regulation | Pharmaceuticals | Public Companies | Biotechnology and Medical Research Companies | New York Stock Exchange (NYSE) | Börse Frankfurt | Tel Aviv Stock Exchange (TASE) | Börse Berlin | Börse München | Börse Stuttgart | Tradegate Exchange | NYSE American | NYSE ARCA Equities | BZX Exchange | BYX Exchange | EDGA Exchange | EDGX Exchange | NYSE National | Nasdaq BX | Nasdaq PSX | Nasdaq Intermarket | FINRA Alternative Display Facility (ADF) | Investors Exchange (IEX) | NYSE Chicago
Copyright ©2006-2024 Public Technologies Inc. | Privacy Policy | Terms of Use | Contact